Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Bristol-Myers Squibb (NY: BMY)
49.19 USD  -0.41 (-0.83%)
Official Closing Price  /  Updated: 7:30 PM EDT, Mar 20, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 17,438,100
Open 49.70
Bid (Size) 49.12 (2)
Ask (Size) 49.30 (1)
Prev. Close 49.60
Today's Range 48.55 - 49.70
52wk Range 44.30 - 67.16
Shares Outstanding 1,634,538,458
Dividend Yield 3.25%
Performance
YTD
-6.18%
-6.18%
1 Month
-4.23%
-4.23%
3 Month
-2.38%
-2.38%
6 Month
-19.10%
-19.10%
1 Year
-25.95%
-25.95%
Top News
More News
Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's Ill-Advised Proposed Acquisition of Celgene
Mails Definitive Proxy Materials and a BLUE Proxy Card for Shareholders to Vote AGAINST the Proposed Transaction at the Upcoming Special Meeting Read More
from PR Newswire
Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene
Bristol-Myers Squibb Company (NYSE: BMY) today filed a new investor presentation with the Securities and Exchange Commission (SEC) in connection with its previously announced definitive merger... Read More
from Business Wire News Releases
More News
Read More
AUGUSTUS Demonstrates Favorable Safety Results of Eliquis® Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronar
from Business Wire News Releases
Hot Options Report For End Of Day - Wednesday, March 20
category Options
from Blogs - TalkMarkets
Amid Bristol-Starboard Duel Over Celgene, Here's What's Really Key
from Investor's Business Daily
Undervalued Growth and Dividend Growth in Health Technology
category Stocks / Equities , Healthcare
from Blogs - TalkMarkets
Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle?
category CELG , BMY , Market News , and 1 more.
from Motley Fool
U.S. FDA approves Roche's small cell lung cancer treatment
category companyNews
from Reuters: Company News
Morgan Stanley Drops Bearish Exelixis Stance, Sees 'Limited Downside Risk'
category PFE , Market News , Analyst Color , and 9 more.
from Benzinga
GSK Prescribes A US$3.5bn Bond In Three Parts
category Stocks / Equities , Healthcare , Bonds
from Blogs - TalkMarkets
XLV, BMY, DHR, CVS: Large Inflows Detected at ETF
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More

© Copyright FinancialContent Services, Inc.
Terms and Conditions Privacy Policy Contact Us twitter linkedin twitter

Contact Us

(888) 688-9880

Services

Financial Widgets Financial Pages Web Services Consulting Financial Calculations Stock Data for Excel Newspaper Services For Advertisers Monetization Services Content Syndication Press Release Syndication

Services by Industry

Online Media Financial Services Newspaper Investor Relations Financial Blog Corporate Intranets Digital Signage Television Android Developers iOS Developers Wire Services Radio

About Us

Overview Careers Management Team Latest News Newsletters

Support

Support Articles Report an issue